Cigna Corp. and Express Scripts shareholders on Friday approved the insurer’s $60 billion acquisition of the pharmacy benefit manager, following a top activist investor’s decision to drop his opposition to the transaction.
Regulatory approval for the deal remains pending, but the companies expect it to close by the end of 2018.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.